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Background
In 1973 Portnoy and Schulte developed the antisiphon-
device for prevention of over drainage, a supplementary
valve with a variable resistance depending on body verti-
calization respect. The variable suction of the water col-
umn in distal catheter. Clones were the SCD (Medtronic)
and SLD (Radionics). All were assembled to other DP-
valves or integrated in bodies combined with conven-
tional valves (Delta, Novus). Unfortunately many cases
with enigmatous hydraulic problems, especially under-
drainage, but also over drainage were observed. In 1989
we identified the cause, the excessive susceptibility on
external pressure, e.g. scars. For the compensation of these
disturbing influences some users combined the antisi-
phons with adjustable Sophy- or Medos-valves. Unfortu-
nately evaluations of these combinations, which
anticipated the later Strata-valve, were not published.
Generally long-term results of antisiphons are rarities.
Materials and methods
We evaluated retrospectively 38 patients with antisiphons
4–22 years after implantation, of them 18 with adjustable
valves. 5 had telemetric ICP sensors.
Results
12/38 antisiphons are still implanted (survival 32%),
each 3 with good, fair, insufficient and poor condition. 20
patients were converted to gravitational, four to adjusta-
ble and one to a simple DP valve. Two became shunt free.
The quote of sufficient results in long-term counted 7.9%
(3/38).
Discussion
34 years after introduction of antisiphons exist only two
prospective randomized series with cumulative 430
Delta/Strata-patients (Drake 98, Kestle 05); both showed
no differences compared to conventional valves in short
term. Generally we found surprisingly few studies,
approx. 50% with standard and 50% with inferior results
(Miyake 99), but only mini-samples with superior data in
short follow-up (Kondageski 07). 8 independent labora-
tory studies confirmed the excessive susceptibility on
external pressure, which plausibly explains the clinical
problems.
Conclusion
In short term, antisiphons show mostly no difference to
other valves, sometimes they are inferior. In the course of
time the specific problems increase and lead to a poor sur-
vival- and success-quote. Adjustable valves may damp, but
are unable to compensate this effect.
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